Aura Biosciences (AURA) Operating Expenses (2020 - 2026)

Aura Biosciences has reported Operating Expenses for 7 years, with the latest figure at $34.9 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 20.08% year-over-year to $34.9 million; the trailing twelve-month figure through Mar 2026 stood at $118.6 million (up 15.35% YoY), and the FY2025 full-year result was $112.8 million, up 17.35% from the prior year.
• Operating Expenses for Q1 2026 stood at $34.9 million, up from $27.2 million in the prior quarter.
• The five-year high for Operating Expenses was $34.9 million in Q1 2026, with the low at $12.8 million in Q1 2022.
• Historically, Operating Expenses has averaged $22.9 million across 5 years, with a median of $22.8 million in 2024.
• Annual changes were most pronounced in 2022 — Operating Expenses soared 174.88% — and 2025, when it declined 2.05%.
• Aura Biosciences' Operating Expenses stood at $17.6 million in 2022, then jumped by 40.71% to $24.8 million in 2023, then climbed by 12.2% to $27.8 million in 2024, then slipped by 2.05% to $27.2 million in 2025, then grew by 28.01% to $34.9 million in 2026.
• The last three Operating Expenses figures came in at $34.9 million (Q1 2026), $27.2 million (Q4 2025), and $27.9 million (Q3 2025), per Business Quant data.